跳至主要内容
临床试验/IRCT2017012932277N1
IRCT2017012932277N1已完成未知

The comparison of duloxetine and pregabalin effects on plasma concentration of nitric oxide (NO) and inducible nitric oxide synthase (iNOS) in type 2 diabetic patients and the role of these mediators in neuropathic pain

The vice chancellor for research affairs of Shahid Beheshti University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
39 years 至 60 years(—)
性别
All

入选标准

  • 1-Type 2 diabetic patients with neuropathic pain which have the pain score over 4 on Visual Analogue Scale (VAS) for more than 3 months; 2-The age range: 40-60 years; 3- The patients should fill out and sign the consent forms
  • Exclusion criteria:
  • 1-Hypersensitivity to Duloxetine and Pregabalin; 2-Kidney or liver failure; 3-Any other neuropathies (spinal cord injury, discopathy, congenital neuropathy, vocational, hypothyroidism, collagen vascular disease, vasculitis, Paraneoplastic disorders, immunological, alcoholism and drugs induced); 4- Rheumatoid Arthritis; 5-Goat; 6-Epilepsy; 7-Orthopedic complications; 8- Vision disability; 9-Intellectual disorders; 10-Usage of analgesic and anti-inflammatory drugs; 11-Type 1 diabetes; 12-Hypertension; 13-Smoking

排除标准

  • 未提供

研究者

发起方
The vice chancellor for research affairs of Shahid Beheshti University of Medical Sciences

相似试验